New microwave tool targets lung tumors without surgery
NCT ID NCT05786625
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new device that uses microwave energy to destroy small lung tumors. The device is inserted through a bronchoscope, avoiding the need for open surgery. The trial will enroll 35 people with lung nodules that are cancerous or highly suspicious, and who cannot have surgery. Researchers will check if the device can safely reach and ablate the tumor, and monitor for side effects like bleeding or lung collapse.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Microwave ablation device (MicroBlate™ Flex AB1)
What this could lead to
If successful, this could provide a new, less invasive treatment option for people with small lung tumors who cannot have surgery.
What could go wrong
This is an early feasibility study with only 35 participants. The device may cause serious side effects like bleeding or lung collapse, and it is not yet proven to control cancer long-term.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Amsterdam University Medical Centres, Location AMC, Meibergdreef 9
Amsterdam, 1105 AZ, Netherlands
-
Royal Brompton and Harefield NHS Foundation Trust
London, SW3 6NP, United Kingdom